Exenatide
BASIC2
AstraZeneca · Phase 3 · Active, not recruiting · Enrollment 63
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Exenatide once weekly extended-release | n/r | n/r | n/r | n/r | n/r |
| Matching placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.